AzTrials
AzTrials

Traumatic FractureNCT05481671

Influencing Factors and Their Approach of Kinesiophobia in Patients With Traumatic Fractures

An observational study of Traumatic Fracture, run by Wei XIA, PhD at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to investigate the relationship between kinesiophobia and pain catastrophizing, as well as the relationship between pain catastrophizing and pain level, anxiety and depression, self-efficacy and psychological resilience in patients with traumatic fractures, and to explain the approach and effect… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Traumatic Fracture
What is being tested?
Questionnaires
How many people
381 participants
Where
1 siteChina
Study dates
2 Oct 2022to 30 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The patients with traumatic fractures admitted to the Orthopedics Department of the three third-class hospitals in Guangzhou from August 2022 to May 2023.

Who may be able to join

  • Patients who were diagnosed as fractures due to accidental trauma and were diagnosed by X-rays and clinicians and required surgical treatment.
  • Age 18 and above.

Who cannot join

  • Those with a history of chronic pain (pain persisting or indirectly persisting for more than 3 months).
  • Those who have serious postoperative complications (such as deep vein thrombosis, infection, etc.) and need other treatment or transfer to another department.
  • People with physical disability or abnormal muscle strength before injury.
  • Those who have a history of mental illness or who have taken anti-anxiety, depression drugs, or cognitive impairment within one month.
  • Patients undergoing emergency surgery on the day of admission.
  • Those who cannot communicate normally due to physical or psychological barriers.

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • XIAW

    Guangzhou, Guangdong, 510080

    Wei Xia, PhD, 18823359471, xiaw23@mail.sysu.edu.cn

    Recruiting

Other trials in China

About this study

This study aims to investigate the relationship between kinesiophobia and pain catastrophizing, as well as the relationship between pain catastrophizing and pain level, anxiety and depression, self-efficacy and psychological resilience in patients with traumatic fractures, and to explain the approach and effect relationship between kinesiophobia and these variables.

Read the detailed description

At present, there are few studies on kinesiophobia in patients with traumatic fractures. This study adopts structural equation model to analyze the current situation of kinesiophobia in patients with traumatic fractures, and explores the effect of pain level, pain catastrophizing, anxiety and depression, self-efficacy and psychological resilience on kinesiophobia in patients with traumatic fractures, which provides a scientific basis for predicting the occurrence of kinesiophobia in patients with traumatic fractures and developing intervention plans.

Being tested
Questionnaires
Keywords
Traumatic Fracture, Kinesiophobia, Pain Catastrophizing, Anxiety, Depression, Self-efficacy, Psychological Resilience
Medical subject headings
Kinesiophobia, Anxiety Disorders, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnairesOther

    Participants will be asked to respond to the Demographic Information Sheet, Tampa Scale for Kinesiophobia, Numeric Rating Scale, Pain Catastrophizing Scale, Hospital Anxiety and Depression Scale, Resilience Scale , Pain Self-efficacy Questionnaires and Functional Exercise Compliance Scale for Orthopaedic Patients.

Study groups in NCT05481671
Study groupRoleWhat they receive
Questionnaires assessed patients with traumatic fractures①Age 18 and above. ②Patients who were diagnosed as fractures due to accidental trauma and were diagnosed by X-rays and clinicians and required surgical treatment. ③Have the normal cognitive ability, expression ability and social participation ability.
Receives: Other: Questionnaires

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. kinesiophobia

    The kinesiophobia level of patients with traumatic fractures will be measured by Tampa Scale for Kinesiophobia(TSK-11). The total score ranges from 11 to 44. A score of more than 26 on the scale is defined as kinesiophobia.

    Measured: baseline

  2. kinesiophobia

    The kinesiophobia level of patients with traumatic fractures will be measured by Tampa Scale for Kinesiophobia(TSK-11). The total score ranges from 11 to 44. A score of more than 26 on the scale is defined as kinesiophobia.

    Measured: 3 days after surgery

  3. functional exercise compliance

    The compliance of functional exercise in patients with traumatic fractures will be measured by Functional Exercise Adherence Scale for Orthopaedic Patients. The total score ranges from 15 to 75. A total score of less than or equal to 20 indicates low compliance; a score of greater than or equal to 55 indicates high compliance; and a score of greater than 20 and less than 50 indicates partial compliance.

    Measured: 3 days after surgery

Secondary outcomes (10)
  1. pain degree

    The pain degree of patients with traumatic fractures will be measured by Numberical Rating Scale. Pain is scored on a scale of 0 to 10, with higher scores indicating higher pain degree.

    Measured: baseline

  2. pain degree

    The pain degree of patients with traumatic fractures will be measured by Numberical Rating Scale. Pain is scored on a scale of 0 to 10, with higher scores indicating higher pain degree.

    Measured: 3 days after surgery

  3. pain catastrophization

    The level of catastrophic pain in patients with traumatic fractures will be measured by Pain Catastrophizing Scale. Scores range from 0 to 52, with higher scores indicating higher levels of catastrophic pain in patients.

    Measured: baseline

  4. pain catastrophization

    The level of catastrophic pain in patients with traumatic fractures will be measured by Pain Catastrophizing Scale. Scores range from 0 to 52, with higher scores indicating higher levels of catastrophic pain in patients.

    Measured: 3 days after surgery

  5. anxiety and depression

    The anxiety and depression of patients with traumatic fractures will be measured by Hospital Anxiety and Depression Scale . The scale score ranges from 0 to 21 points, 0 to 7 points for no anxiety or depression, 8 to 10 points for suspicious symptoms of anxiety or depression, and greater than or equal to 11 points for psychological disorders.

    Measured: baseline

  6. anxiety and depression

    The anxiety and depression of patients with traumatic fractures will be measured by Hospital Anxiety and Depression Scale . The scale score ranges from 0 to 21 points, 0 to 7 points for no anxiety or depression, 8 to 10 points for suspicious symptoms of anxiety or depression, and greater than or equal to 11 points for psychological disorders.

    Measured: 3 days after surgery

  7. self-efficacy

    The self-efficacy of patients with traumatic fractures will be measured by Pain Self-efficacy Scale. The total score ranges from 0 to 60, with higher scores indicating higher pain self-efficacy.

    Measured: baseline

  8. self-efficacy

    The self-efficacy of patients with traumatic fractures will be measured by Pain Self-efficacy Scale. The total score ranges from 0 to 60, with higher scores indicating higher pain self-efficacy.

    Measured: 3 days after surgery

  9. psychological resilience

    The psychological resilience of patients with traumatic fractures will be measured by Resilience Scale (CD-RISC-10). The total score ranges from 0 to 40, with higher scores indicating higher psychological resilience.

    Measured: baseline

  10. psychological resilience

    The psychological resilience of patients with traumatic fractures will be measured by Resilience Scale (CD-RISC-10). The total score ranges from 0 to 40, with higher scores indicating higher psychological resilience.

    Measured: 3 days after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Aug 2022
  2. Study start2 Oct 2022
  3. Primary completion31 May 2023 (estimated)
  4. Study completion30 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Other
Enrolment
381 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05481671
Sponsor's protocol ID
kinesiophobia(fracture)2022.07
Status last verified
Oct 2022
First submitted
24 Jul 2022
Last updated
12 Oct 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Traumatic Fracture, run by Wei XIA, PhD at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Wei Xia, PhD (+86-18823359471, xiaw23@mail.sysu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

kinesiophobia (time frame: baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Oct 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in